According to Gram Research analysis, adults eligible for GLP-1 weight loss medications eat significantly lower-quality diets than those who don’t qualify, with diet quality scores averaging 49.2 compared to 51.7 for non-eligible adults in a 2026 study of 16,143 Americans. These eligible adults consumed fewer fruits, vegetables, whole grains, and plant proteins, and showed gaps in vitamin C, vitamin D, magnesium, and potassium intake. Researchers recommend nutrition assessment and counseling as part of comprehensive obesity treatment alongside medication.

A large study of nearly 100 million Americans found that people eligible for GLP-1 weight loss medications (like Ozempic and Wegovy) tend to eat lower-quality diets with fewer fruits, vegetables, and whole grains compared to people who don’t need these drugs. Researchers discovered that people eligible for these medications had vitamin and mineral gaps, particularly in vitamin C, vitamin D, and potassium. The good news: the study suggests that nutrition counseling should be part of treatment plans for people using these medications, helping them eat better while the drugs help them lose weight.

Key Statistics

A 2026 cross-sectional analysis of 16,143 U.S. adults found that 43.5% met eligibility criteria for GLP-1 weight loss medications, representing approximately 97.7 million Americans.

Adults eligible for GLP-1 medications had diet quality scores 2.5 points lower than non-eligible adults (49.2 vs 51.7 on the Healthy Eating Index), according to a nationally representative 2026 study.

Among people eligible for GLP-1 medications, micronutrient inadequacy was higher for vitamin C, vitamin A, magnesium, vitamin E, vitamin D, fiber, potassium, and vitamin K compared to non-eligible adults in a 2026 analysis of 16,143 Americans.

Higher waist circumference was independently associated with approximately 1.47 points lower diet quality scores per quartile increase in a 2026 study of 16,143 U.S. adults.

The Quick Take

  • What they studied: Whether people who qualify for GLP-1 weight loss medications eat differently and get enough vitamins and minerals compared to people who don’t qualify for these drugs.
  • Who participated: Nearly 16,000 American adults surveyed between 2005 and 2020, representing about 97.7 million U.S. adults. The study included people of all ages 20 and older with different body weights and health conditions.
  • Key finding: Adults eligible for GLP-1 medications had noticeably lower diet quality scores (49.2 out of a possible higher score versus 51.7 for non-eligible adults). They also had more vitamin and mineral gaps, especially for vitamin C, vitamin D, magnesium, and potassium.
  • What it means for you: If you’re considering or taking GLP-1 weight loss medications, talking to a nutritionist about improving your diet quality could help you get better results. These medications work best when combined with eating more fruits, vegetables, whole grains, and plant-based proteins.

The Research Details

Researchers looked at real-world data from the National Health and Nutrition Examination Survey (NHANES), which tracks what Americans eat and their health. They identified people who would qualify for GLP-1 medications based on standard medical criteria: having a BMI of 30 or higher, or a BMI of 27 or higher with weight-related health problems like diabetes or high blood pressure.

They then compared what these eligible people ate to what people who didn’t qualify ate. They used a scoring system called the Healthy Eating Index (HEI-2015) that rates diet quality based on how much of different food groups people consume. They also checked whether people were getting enough vitamins and minerals by comparing their intake to official nutrition guidelines.

The researchers adjusted their analysis to account for factors like age, income, race, and other health conditions that might affect both diet quality and weight. This helps them understand whether the diet differences were truly related to GLP-1 eligibility or just due to other factors.

This approach is important because it shows real-world patterns in how people eat before they start treatment. Understanding baseline nutrition problems helps doctors and nutritionists create better treatment plans. It also helps explain why some people might benefit more from nutrition counseling alongside medication.

This study used nationally representative data, meaning the results apply to the broader U.S. population, not just a small group. The sample size was large (over 16,000 people), which makes the findings more reliable. However, because it’s a cross-sectional study (a snapshot in time rather than following people over years), it shows associations but can’t prove that poor diet causes weight gain or vice versa. The study also relied on people’s memory of what they ate, which can be imperfect.

What the Results Show

The study found that 43.5% of U.S. adults meet the criteria for GLP-1 weight loss medications. This is a substantial portion of the population—nearly 100 million Americans. Among these eligible adults, diet quality was consistently lower than among people who didn’t qualify.

When researchers looked at specific foods, people eligible for GLP-1 medications ate fewer fruits, vegetables, whole grains, and plant-based proteins. These are the foods that provide the most vitamins, minerals, and fiber. The difference in overall diet quality remained even after accounting for age, income, race, and other factors—though it became smaller when researchers adjusted for belly fat specifically.

Micronutrient gaps were common among eligible adults. More of them weren’t getting enough vitamin C (from fruits and vegetables), vitamin D (from fortified foods and sunlight), magnesium (from nuts and leafy greens), potassium (from fruits and vegetables), and fiber (from whole grains and plants). These nutrients are important for bone health, immune function, heart health, and digestion.

The study found that belly fat (measured by waist circumference) was strongly linked to poor diet quality. For every increase in waist size category, diet quality scores dropped by about 1.47 points. This suggests that where someone carries extra weight matters for understanding their eating patterns. People with more belly fat tended to eat lower-quality diets, regardless of their overall weight.

Previous research has shown that people with obesity often have nutritional gaps, but this study provides detailed, nationally representative data specifically for people who would qualify for newer GLP-1 medications. It confirms what smaller studies suggested: that poor diet quality and obesity often go together. The findings align with research showing that weight loss medications work best when combined with lifestyle changes, including better nutrition.

This study captures a moment in time and doesn’t follow people over years, so it can’t prove that poor diet causes weight gain or that improving diet will prevent obesity. The study relied on people remembering what they ate, which isn’t always accurate. Additionally, the study couldn’t determine whether people’s poor diet quality caused their weight problems or whether their weight problems led to poor eating habits. Finally, the study doesn’t tell us whether improving diet quality while taking GLP-1 medications leads to better health outcomes.

The Bottom Line

If you’re eligible for or taking GLP-1 weight loss medications, work with a doctor or registered dietitian to improve your diet quality. Focus on eating more fruits, vegetables, whole grains, and plant-based proteins. Consider taking a multivitamin or mineral supplement, especially for vitamin D and magnesium, until your diet improves. These steps should be combined with the medication for best results. Confidence level: Moderate to High—this is based on strong evidence that diet quality matters for overall health and weight management.

Anyone considering GLP-1 medications should pay attention to these findings. People with obesity, type 2 diabetes, or heart disease should especially consider nutrition counseling. Healthcare providers prescribing these medications should discuss nutrition as part of treatment. People without weight problems or those already eating high-quality diets may not need to change their approach.

Improving diet quality takes time. You might notice better energy levels and digestion within 2-4 weeks of eating more fruits and vegetables. Weight loss benefits from improved nutrition combined with medication typically become noticeable within 4-8 weeks. Long-term health benefits from better nutrition take months to years to fully develop.

Frequently Asked Questions

Do people who take GLP-1 weight loss drugs have bad diets?

Research shows that people eligible for GLP-1 medications tend to eat lower-quality diets with fewer fruits, vegetables, and whole grains. A 2026 study of 16,143 Americans found their diet quality scores were 2.5 points lower than non-eligible adults, though the difference is modest.

What vitamins and minerals are people on GLP-1 drugs missing?

People eligible for GLP-1 medications commonly lack adequate vitamin C, vitamin D, magnesium, potassium, and fiber. A 2026 nationally representative study found these micronutrient gaps were more common among eligible adults, suggesting supplementation or dietary improvements may be beneficial.

Should I see a nutritionist if I’m taking GLP-1 medications?

Yes. A 2026 study recommends nutrition assessment as part of comprehensive obesity treatment with GLP-1 medications. Working with a dietitian to improve diet quality—eating more fruits, vegetables, whole grains, and plant proteins—can enhance medication effectiveness and address nutritional gaps.

Can GLP-1 drugs work without improving your diet?

GLP-1 medications can help with weight loss on their own, but research suggests combining them with better nutrition produces better results. A 2026 study found that people eligible for these drugs eat lower-quality diets, indicating nutrition improvement could optimize treatment outcomes.

How long does it take to see health benefits from eating better while on GLP-1 drugs?

You may notice improved energy and digestion within 2-4 weeks of eating more nutrient-dense foods. Weight loss benefits typically become noticeable within 4-8 weeks when diet improvements are combined with medication. Long-term health benefits develop over months to years.

Want to Apply This Research?

  • Log daily servings of fruits, vegetables, whole grains, and plant proteins. Aim for at least 2 cups of vegetables, 1.5 cups of fruit, 3 ounces of whole grains, and 5-6 ounces of plant proteins daily. Track weekly vitamin D and magnesium intake through food sources or supplements.
  • Set a weekly goal to try one new vegetable or whole grain you haven’t eaten before. Replace one refined grain (white bread, regular pasta) with a whole grain version each week. Add one plant-based protein source (beans, lentils, tofu) to your meals three times per week.
  • Use the app to track diet quality scores weekly using a simplified Healthy Eating Index approach. Monitor energy levels, digestion, and how clothes fit as non-scale markers of progress. Check in monthly with a healthcare provider or dietitian to review nutrition improvements and adjust supplementation if needed.

This article summarizes research findings and should not be considered medical advice. If you are considering GLP-1 medications or making dietary changes, consult with your healthcare provider or a registered dietitian. Individual nutritional needs vary based on health conditions, medications, and other factors. This study shows associations but cannot prove causation. Always discuss nutrition and supplementation with your doctor before making changes, especially if you have existing health conditions or take other medications.

This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.

Source: Diet Quality and Micronutrient Intake Among U.S. Adults Eligible for GLP-1 Receptor Agonist Anti-Obesity Medications: A Nationally Representative Analysis.The Journal of nutrition (2026). PubMed 42520970 | DOI